Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Association for Accessible Medicines (AAM), the ERISA Industry Committee (ERIC), the American Society of Health-System Pharmacists (ASHP … Bartlett, Senior Vice President, Health Policy, The ERISA Industry Committee (ERIC) “The bipartisan Expedited Access to Biosimilars